To investigate whether changes to Ca2+ flux observed at early time points in SMF-treated cells (Figure 1) impacted endpoints relevant to PD in PC12 cells over longer time periods, we measured A2AR mRNA and protein levels. The gene discussed is ADORA2A; the disease is Parkinson disease.